Pharma Focus Europe


Pharma manufacturing techniques necessary to create pharmaceutical services are included in manufacturing processes. These procedures outline the minimal standards that pharmaceutical firms must and ought to meet to deliver high-caliber goods that don't endanger patients or consumers as a whole. Drug makers hire a company to produce completed goods or parts using pharmaceutical machinery in the pharmaceutical contract manufacturing process. It might be considered a form of outsourcing. Focusing on what they do best for customers, partners, or external vendors is how businesses flourish. Contract manufacturing appears to be a perfect fit in this situation.

Lean Supply Chain Management in Pharma Sector

In the pharmaceutical industry, where efficiency and adaptability are crucial, companies face unique challenges ranging from stringent regulations to complex manufacturing processes.

Genomic Medicine Keeps Innovating and Manufacturing Needs to Keep Pace

Genomic medicine — the therapeutic use of cells and genetic materials — is at the center of a medical revolution.

Safeguarding Sterility

Crucial Insights from 2023 Pharmaceutical Facility Audits

The sterile pharmaceutical market is expected to expand significantly in the coming years due to the increasing demand for biological drugs...

Advanced Pharmaceutical Continuous Manufacturing of Liquid Dosage Forms

Continuous manufacturing methods have been extensively demonstrated to have a significant impact on improving quality...

Emerging role of Mass Spectrometry in Biologics Development

After a lead protein design is selected for clinical trials, biologics manufacturing (also known as chemistry manufacturing and control...

Pharma 4.0: Advanced Continuous Pharmaceutical Tablet Manufacturing

Currently, Industry 4.0 concepts are being applied to the pharmaceutical industry to achieve Pharma 4.0 paradigm.

Biopharmaceutical Supply Chain

The biopharmaceutical industry is a highly regulated and complex industry, where the timely and safe delivery of life-saving treatments to patients is of utmost importance.

Cold-Chain Considerations for Manufacturing today’s Advanced Biologics

Cold Chain Integrity and Capabilities

The biopharmaceutical industry’s reliance on the technical experience and manufacturing capacity of contract pharma continues to grow as demand for all biologic drugs surges around the world.

3D Printing: What's in Store for Medicine in the Future

3D printing technology, also known as additive manufacturing, is a digitally-controlled technique of fabricating a product by layer-wise addition of the feed material to generate complex geometric structures.

Additive Manufacturing as a Problem-Solving Tool in Pharmaceutical Processing

A hybrid raxial mixing impeller is designed and implemented to resolve dispersion mixing issues in a pharmaceutical application

At the core of the transition to Industry 4.0 is the drive toward robust, reliable and comprehensive process automation.

Sustainable Packaging

Pharma to take care of the planet

The top five drivers of this move to sustainability, according to the Packaging Sustainability: A Changing Landscape report from PMMI, The Association for Packaging and Processing Technologies, include brand perception, competitive pressure, environmental advocates, top-down company culture and good stewards of the planet.


Operating in one of the most demanding and highly regulated environments, pharmaceutical companies face the constant challenge of managing medicinal product information for regulatory labelling submissions that comply with regional and national agency requirements.



The biotherapeutics market is booming. Currently, annual growth rate of biologics is double that of conventional pharma and is forecasted to grow rapidly. Increase in incidence of chronic diseases like cancer, diabetes, autoimmune diseases, genetic conditions…etc and acceptance of biotherapeutics because of their high efficacy and safety are some o...

Human Vaccine Candidates Discovery and Development on Non-Animal Systems

An adoption with meaningful repercussions

A vaccine is traditionally a biological substance containing a harmless form of the causative organism that causes a particular disease. It is usually given to healthy population by injection, to prevent the contraction of the disease.


Current situation and future perspectives

As a rule of thumb in epidemiology, the world faces a pandemic once every 100 years. The previous one was the Spanish flu in 1918. At the end of World War I, a new strain of the influenza virus, H1N1, broke out in the United States.

Ensuring Efficiency in Packaging Process should be a top Priority for Pharma Packaging Companies

The pharmaceutical industry is one where decades of innovation lead to one new product, like a drug or vaccine.


Lung infections, especially lower respiratory tract infections are one of the leading causes of transmissible deaths worldwide according the world health organisation.

Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics

People respond very differently to medications depending on their weight, age, inborn capability to metabolize drugs, the individual characteristics of the disease, or the presence of co-morbidities. The well-known assumption that “one size fits all” has clearly revealed all its limitations and become questionable. Notably, among humans, pediatric...

Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024